UNITED GUARDIAN conducts research, product development, manufacturing and marketing of pharmaceuticals, cosmetics, health care products, medical devices, and proprietary industrial products. They also distributes a line of over 3,000 fine organic chemicals, research chemicals, test solutions, indicators, dyes and reagents.
| Revenue (Most Recent Fiscal Year) | $12.18M |
| Net Income (Most Recent Fiscal Year) | $3.25M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | 13.19 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 3.35 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.52 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 11.41 |
| Pre-Tax Margin (Trailing 12 Months) | 32.00% |
| Net Margin (Trailing 12 Months) | 25.31% |
| Return on Equity (Trailing 12 Months) | 24.98% |
| Return on Assets (Trailing 12 Months) | 21.52% |
| Current Ratio (Most Recent Fiscal Quarter) | 6.06 |
| Quick Ratio (Most Recent Fiscal Quarter) | 5.28 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 3.98 |
| Book Value per Share (Most Recent Fiscal Quarter) | $2.36 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $0.63 |
| Exchange | NASDAQ |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Common Shares Outstanding | 4.59M |
| Free Float | 3.26M |
| Market Capitalization | $38.18M |
| Average Volume (Last 20 Days) | 5867.45 |
| Beta (Past 60 Months) | 0.95 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 29.00% |
| Percentage Held By Institutions (Latest 13F Reports) | 23.16% |
| Annual Dividend (Based on Last Quarter) | $0.70 |
| Dividend Yield (Based on Last Quarter) | 8.42% |